Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. [electronic resource]
Producer: 20090602Description: 921-7 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Squamous Cell -- drug therapy
- Chemotherapy, Adjuvant
- Cisplatin -- administration & dosage
- Disease-Free Survival
- Docetaxel
- Female
- Fluorouracil -- administration & dosage
- Humans
- Hypopharyngeal Neoplasms -- drug therapy
- Kaplan-Meier Estimate
- Laryngeal Neoplasms -- drug therapy
- Laryngectomy
- Male
- Middle Aged
- Proportional Hazards Models
- Radiotherapy, Adjuvant
- Risk Assessment
- Taxoids -- administration & dosage
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.